| |
| |
|
| Insider
Information: |
Hanish Arnold C |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
19,051 |
|
|
Indirect Shares
|
22,844 |
|
|
| Direct
Value |
$13,385,234 |
|
|
|
Indirect Value
|
$6,573,049 |
|
|
| Total
Shares |
41,895 |
|
|
| Total
Value |
$19,958,283 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -48.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
Chief Accounting Officer |
2012-08-29 |
17,611 |
2012-08-29 |
8,590 |
Premium* |
|
|
Omeros Corp |
OMER |
|
2023-05-22 |
0 |
2023-05-22 |
12,400 |
Premium* |
|
|
Salarius Pharmaceuticals, Inc |
SLRX |
Director |
2023-01-03 |
1,440 |
2023-01-03 |
1,854 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OMER |
Omeros Corp |
Director |
– • – |
2012-09-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
400 |
|
- |
|
| LLY |
Eli Lilly & Co |
Chief Accounting Officer |
• – – |
2003-04-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,800 |
17,875 |
|
- |
|
| LLY |
Eli Lilly & Co |
Chief Accounting Officer |
• – – |
2003-04-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,000 |
2,500 |
|
- |
|
| LLY |
Eli Lilly & Co |
Chief Accounting Officer |
• – – |
2003-04-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
63 |
17,812 |
|
- |
|
| LLY |
Eli Lilly & Co |
Chief Accounting Officer |
• – – |
2003-07-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
75 |
17,737 |
|
- |
|
| LLY |
Eli Lilly & Co |
Chief Accounting Officer |
• – – |
2004-03-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
117 |
6,823 |
|
- |
|
| LLY |
Eli Lilly & Co |
Chief Accounting Officer |
• – – |
2004-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
9,823 |
|
- |
|
| LLY |
Eli Lilly & Co |
Chief Accounting Officer |
• – – |
2005-06-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
221 |
11,900 |
|
- |
|
| LLY |
Eli Lilly & Co |
Chief Accounting Officer |
• – – |
2006-06-26 |
5 |
GD |
$0.00 |
$0 |
D/D |
115 |
14,071 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Chief Accounting Officer |
• – – |
2007-04-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
125 |
15,241 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Chief Accounting Officer |
• – – |
2009-08-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
187 |
16,778 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Chief Accounting Officer |
• – – |
2010-03-04 |
5 |
GD |
$0.00 |
$0 |
D/D |
232 |
17,251 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Chief Accounting Officer |
• – – |
2011-05-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
243 |
20,423 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Chief Accounting Officer |
• – – |
2012-05-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
238 |
19,042 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Chief Accounting Officer |
• – – |
2012-08-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
136 |
17,611 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Director |
– • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,440 |
1,440 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Director |
– • – |
2020-08-21 |
4/A |
B |
$0.98 |
$3,920 |
I/I |
4,000 |
11,350 |
2.1 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Director |
– • – |
2020-08-21 |
4 |
B |
$0.98 |
$3,920 |
D/D |
4,000 |
11,350 |
2.31 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Director |
– • – |
2020-02-11 |
4/A |
B |
$1.15 |
$5,003 |
I/I |
4,350 |
7,350 |
2.1 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Director |
– • – |
2020-02-11 |
4 |
B |
$1.15 |
$5,003 |
D/D |
4,350 |
7,350 |
2.39 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Director |
– • – |
2022-06-03 |
4 |
B |
$0.18 |
$5,152 |
I/I |
28,000 |
46,350 |
2.1 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Director |
– • – |
2021-08-10 |
4 |
B |
$0.88 |
$6,167 |
I/I |
7,000 |
18,350 |
2.1 |
- |
|
| LLY |
Eli Lilly & Co |
Chief Accounting Officer |
• – – |
2004-06-16 |
4 |
OE |
$14.66 |
$10,260 |
D/D |
700 |
10,523 |
|
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Director |
– • – |
2019-11-25 |
4/A |
B |
$3.59 |
$10,770 |
D/D |
3,000 |
3,000 |
2.39 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
Director |
– • – |
2019-11-25 |
4/A |
B |
$3.59 |
$10,770 |
I/I |
3,000 |
3,000 |
2.1 |
- |
|
52 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
